drug solution / Treatment of hepatitis C / AIDS Treatment / Care for individuals living with both diseases / treatment for sexually transmitted diseases / HIV PREVENTION / on-line training / preparation equipment / Treatment for either disease / AIDS care / Treatment for each of these diseases / Treatment for each disease / treatment for hepatitis C / /
MedicalCondition
hepatitis A / HIV / serious liver disease / liver failure / cirrhosis / hepatitis C / hepatitis B / hepatitis / End-stage liver disease / liver disease / both diseases / HIV infection / either disease / chronic viral hepatitis / disease / viral hepatitis infection / AIDS-defining illness / Clinical Infectious Diseases / virus infection / opportunistic infection / liver cancer / early-untreated HIV infection / diseases / each disease / AIDS / HIV/AIDS / infection / Viral Hepatitis / human immunodeficiency virus infection / chronic hepatitis C / sexually transmitted diseases / CDC’s Viral Hepatitis / /
Food and Drug Administration / Centers for Disease Control and Prevention / Department of Health and Human Services / Academy for Educational Development / / /
Position
Coinfected IDUs General / CDC HIV prevention project officer / /
Product
drug / ribavirin / Preventing Blood-borne Infections Among Injection / CD4+ / /
PublishedMedium
Antiviral Research / Clinical Infectious Diseases / New England Journal of Medicine / /
IDU HIV